APO RESEARCH · REPORT
Targeted RNA Sequencing
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
Product & engineering
Understand the product.
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
In the report, we only collect information about the companies who can provide targeted RNA sequencing service.
Selected research
Industry Growth & Trends
Global Targeted RNA Sequencing Industry Growth and Trends Forecast to 2032
Market perspective
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
In the report, we only collect information about the companies who can provide targeted RNA sequencing service.
According to APO Research, the global Targeted RNA Sequencing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Read the full market overview
Report Scope
This report provides a structured, data-driven view of the global Targeted RNA Sequencing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Targeted RNA Sequencing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Targeted RNA Sequencing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Targeted RNA Sequencing.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Targeted RNA Sequencing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Targeted RNA Sequencing Market by Company
Thermo Fisher
Illumina
Roche Holdings
BGI
Eurofins
LabCorp
Berry Genomics
Macrogen
GENEWIZ
Targeted RNA Sequencing Segment by Type
Exome Sequencing
Enrichment Sequencing
Amplicon Sequencing
Targeted RNA Sequencing Segment by Application
Research Institutes
Hospitals & Clinics
Biotechnology Company
Diagnostic Lab
Targeted RNA Sequencing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Targeted RNA Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Targeted RNA Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Targeted RNA Sequencing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Targeted RNA Sequencing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Exome Sequencing
- Enrichment Sequencing
- Amplicon Sequencing
Applications
- Research Institutes
- Hospitals & Clinics
- Biotechnology Company
- Diagnostic Lab
Companies covered
- Thermo Fisher
- Illumina
- Roche Holdings
- BGI
- Eurofins
- LabCorp
- Berry Genomics
- Macrogen
- GENEWIZ
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Targeted RNA Sequencing Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Targeted RNA Sequencing Market Size by Region (2021-2032)
- 1.4.1 Global Targeted RNA Sequencing Market Size by Region (2021-2026)
- 1.4.2 Global Targeted RNA Sequencing Market Size by Region (2027-2032)
- 1.5 Key Regions Targeted RNA Sequencing Market Size (2021-2032)
- 1.5.1 North America Targeted RNA Sequencing Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Targeted RNA Sequencing Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Targeted RNA Sequencing Market Size Growth Rate (2021-2032)
- 1.5.4 South America Targeted RNA Sequencing Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Targeted RNA Sequencing Market Size Growth Rate (2021-2032)
2 Targeted RNA Sequencing Market by Type
- 2.1 Type Introduction
- 2.1.1 Exome Sequencing
- 2.1.2 Enrichment Sequencing
- 2.1.3 Amplicon Sequencing
- 2.2 Global Targeted RNA Sequencing Market Size by Type
- 2.2.1 Global Targeted RNA Sequencing Market Size Overview by Type (2021-2032)
- 2.2.2 Global Targeted RNA Sequencing Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Targeted RNA Sequencing Market Size Forecasted by Type (2027-2032)
- 2.3 Global Targeted RNA Sequencing Market Size by Regions
- 2.3.1 North America Targeted RNA Sequencing Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Targeted RNA Sequencing Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Targeted RNA Sequencing Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Targeted RNA Sequencing Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Targeted RNA Sequencing Market Size Breakdown by Type (2021-2026)
3 Targeted RNA Sequencing Market by Application
- 3.1 Type Introduction
- 3.1.1 Research Institutes
- 3.1.2 Hospitals & Clinics
- 3.1.3 Biotechnology Company
- 3.1.4 Diagnostic Lab
- 3.2 Global Targeted RNA Sequencing Market Size by Application
- 3.2.1 Global Targeted RNA Sequencing Market Size Overview by Application (2021-2032)
- 3.2.2 Global Targeted RNA Sequencing Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Targeted RNA Sequencing Market Size Forecasted by Application (2027-2032)
- 3.3 Global Targeted RNA Sequencing Market Size by Regions
- 3.3.1 North America Targeted RNA Sequencing Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Targeted RNA Sequencing Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Targeted RNA Sequencing Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Targeted RNA Sequencing Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Targeted RNA Sequencing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Targeted RNA Sequencing Industry Trends
- 4.2 Targeted RNA Sequencing Industry Drivers
- 4.3 Targeted RNA Sequencing Industry Opportunities and Challenges
- 4.4 Targeted RNA Sequencing Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Targeted RNA Sequencing Revenue (2021-2026)
- 5.2 Global Targeted RNA Sequencing Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Targeted RNA Sequencing Key Company Headquarters & Area Served
- 5.4 Global Targeted RNA Sequencing Company, Product Type & Application
- 5.5 Global Targeted RNA Sequencing Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Targeted RNA Sequencing Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Targeted RNA Sequencing Players Market Share by Revenue in 2025
- 5.6.3 2025 Targeted RNA Sequencing Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Thermo Fisher
- 6.1.1 Thermo Fisher Company Information
- 6.1.2 Thermo Fisher Business Overview
- 6.1.3 Thermo Fisher Targeted RNA Sequencing Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Thermo Fisher Targeted RNA Sequencing Product Portfolio
- 6.1.5 Thermo Fisher Recent Developments
- 6.2 Illumina
- 6.2.1 Illumina Company Information
- 6.2.2 Illumina Business Overview
- 6.2.3 Illumina Targeted RNA Sequencing Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Illumina Targeted RNA Sequencing Product Portfolio
- 6.2.5 Illumina Recent Developments
- 6.3 Roche Holdings
- 6.3.1 Roche Holdings Company Information
- 6.3.2 Roche Holdings Business Overview
- 6.3.3 Roche Holdings Targeted RNA Sequencing Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Roche Holdings Targeted RNA Sequencing Product Portfolio
- 6.3.5 Roche Holdings Recent Developments
- 6.4 BGI
- 6.4.1 BGI Company Information
- 6.4.2 BGI Business Overview
- 6.4.3 BGI Targeted RNA Sequencing Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 BGI Targeted RNA Sequencing Product Portfolio
- 6.4.5 BGI Recent Developments
- 6.5 Eurofins
- 6.5.1 Eurofins Company Information
- 6.5.2 Eurofins Business Overview
- 6.5.3 Eurofins Targeted RNA Sequencing Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Eurofins Targeted RNA Sequencing Product Portfolio
- 6.5.5 Eurofins Recent Developments
- 6.6 LabCorp
- 6.6.1 LabCorp Company Information
- 6.6.2 LabCorp Business Overview
- 6.6.3 LabCorp Targeted RNA Sequencing Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 LabCorp Targeted RNA Sequencing Product Portfolio
- 6.6.5 LabCorp Recent Developments
- 6.7 Berry Genomics
- 6.7.1 Berry Genomics Company Information
- 6.7.2 Berry Genomics Business Overview
- 6.7.3 Berry Genomics Targeted RNA Sequencing Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Berry Genomics Targeted RNA Sequencing Product Portfolio
- 6.7.5 Berry Genomics Recent Developments
- 6.8 Macrogen
- 6.8.1 Macrogen Company Information
- 6.8.2 Macrogen Business Overview
- 6.8.3 Macrogen Targeted RNA Sequencing Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Macrogen Targeted RNA Sequencing Product Portfolio
- 6.8.5 Macrogen Recent Developments
- 6.9 GENEWIZ
- 6.9.1 GENEWIZ Company Information
- 6.9.2 GENEWIZ Business Overview
- 6.9.3 GENEWIZ Targeted RNA Sequencing Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 GENEWIZ Targeted RNA Sequencing Product Portfolio
- 6.9.5 GENEWIZ Recent Developments
7 North America
- 7.1 North America Targeted RNA Sequencing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Targeted RNA Sequencing Market Size by Country (2021-2026)
- 7.3 North America Targeted RNA Sequencing Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Targeted RNA Sequencing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Targeted RNA Sequencing Market Size by Country (2021-2026)
- 8.3 Europe Targeted RNA Sequencing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Targeted RNA Sequencing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Targeted RNA Sequencing Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Targeted RNA Sequencing Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Targeted RNA Sequencing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Targeted RNA Sequencing Market Size by Country (2021-2026)
- 10.3 South America Targeted RNA Sequencing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Targeted RNA Sequencing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Targeted RNA Sequencing Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Targeted RNA Sequencing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst